From: Aripiprazole Augmentation in the Treatment of Military-Related PTSD with Major Depression: a retrospective chart review
Measure
Responders (%)
1-month (t2) (n = 27)
2-months (t3) (n = 27)
3-month (t4) (n = 27)
PCL
7(25.93%)
9(33.33%)
10(37.04%)
BDI
1(3.70%)
4(14.81%)
5(18.52%)